Skip to main content

Table 1 Baseline Characteristics of Seroconverter HBM in the MACS Data

From: Methods of competing risks flexible parametric modeling for estimation of the risk of the first disease among HIV infected men

Variables

*patients

AIDS

(N = 267)

Non-AIDS

(N = 156)

Death

(N = 25)

MACS recruitment

N = 674

   

1984–85 & 1987–90

581(86.20)

266(99.63)

132(84.62)

23(92.00)

2001–3 & 2010

93(13.80)

1(0.37)

24(15.38)

2(8.00)

Age at diagnosis

N = 667

   

<40

473(70.91)

205(77.36)

94(60.26)

14(58.33)

≥40

194(29.09)

60(22.64)

62(39.74)

10(41.67)

Baseline CD4, per μl

N = 629

   

< 350

51(8.11)

22(8.84)

9(6.04)

0(0.00)

350–500

102(16.22)

47(18.88)

16(10.74)

6(31.58)

≥500

476(75.68)

180(72.29)

124(83.22)

13(68.42)

Baseline CD8, per μl

N = 629

   

< 500

91(14.47)

45(18.07)

17(11.41)

4(21.05)

500–1000

337(53.58)

129(51.81)

79(53.02)

12(63.16)

≥1000

201(31.96)

75(30.12)

53(35.57)

3(15.79)

Baseline WBC, per μl

N = 663

   

< 5000

191(28.81)

78(29.43)

39(25.32)

10(43.48)

≥5000

472(71.19)

187(70.57)

115(74.68)

13(56.52)

Baseline RBC, × 105, per μl

N = 667

   

<4.5

90(13.49)

25(9.43)

31(19.87)

1(4.17)

≥4.5

577(86.51)

240(90.57)

125(80.13)

23(95.83)

Baseline platelets, × 103, per μl

N = 660

   

< 150

40(6.06)

10(3.77)

9(5.92)

6(26.09)

150–250

347(52.58)

127(47.92)

90(59.21)

8(34.78)

≥250

273(41.36)

128(48.30)

53(34.87)

9(39.13)

  1. *Differences between the number of patients and the sum of the AIDS, Non-AIDS and Death columns indicate the number of censored patients